[{"testset":{"tests":[{"testcase":{"tag":"@TestCaseId(\"LS-26075_02\")","time":"2019-06-18 09:53:51","title":"Regulatory Designations Ontology - Sort Order","steps":[{"date":"2019-06-18 09:53:51","title":"I am authenticated user accessing &quot;REST&quot; API","status":"passed"},{"date":"2019-06-18 09:53:51","StepAttachment":[{"mime":"TXT","content":"aHR0cDovL213Yi51cy13ZXN0LTIuc3RhYmxlLmRldi5jb3J0ZWxsaXMuaW50LmNsYXJpdmF0ZS5jb206ODM0My9tci9SZXN0T250b2xvZ3lTZXJ2aWNlL3YyL3RheG9ub215L1JlZ3VsYXRvcnlEZXNpZ25hdGlvbnMvTmFtZS9yb290"},{"mime":"TXT","content":"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"},{"mime":"TXT","content":"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"}],"title":"I pass a &quot;operation = RegulatoryDesignations/Name&quot; as parameter to &quot;Ontology_v2_root&quot; operation","status":"passed"},{"date":"2019-06-18 09:53:51","substeps":[{"date":"2019-06-18 09:53:51","message":"DB Values returned for the query are: Accelerated Approval, Advanced Therapy Medicinal Product, Animal Rule, Breakthrough Therapy, Emergency Use Authorization, Fast Track, National Science and Technology Major Project, New Active Substance, Orphan Drug, PRIME, Paediatric Investigation Plan, Priority Review, Promising Innovative Medicine, Qualified Infectious Disease Product, Rare Pediatric Disease, Regenerative Medicine Advanced Therapy, Sakigake, Special Review Project, Tropical Disease Priority Review, ","status":"passed"},{"date":"2019-06-18 09:53:51","message":"Values returned in the response are: Accelerated Approval, Advanced Therapy Medicinal Product, Animal Rule, Breakthrough Therapy, Emergency Use Authorization, Fast Track, National Science and Technology Major Project, New Active Substance, Orphan Drug, PRIME, Paediatric Investigation Plan, Priority Review, Promising Innovative Medicine, Qualified Infectious Disease Product, Rare Pediatric Disease, Regenerative Medicine Advanced Therapy, Sakigake, Special Review Project, Tropical Disease Priority Review, ","status":"passed"},{"date":"2019-06-18 09:53:51","message":"Values in the response and DB match","status":"passed"}],"StepAttachment":[{"mime":"TXT","content":"ICAgICAgICAgIHNlbGVjdCBERVNJR05BVElPTl9OQU1FIGZyb20gQ0lfUFVCTElDX1NUQUdJTkcuSlBfUkVHVUxBVE9SWV9ERVNJR05BVElPTl9MSVNUIHdoZXJlIENBVEVHT1JZX0lEID0gJzMnIG9yZGVyIGJ5IFNPUlRPUkRFUiAgICAg"}],"title":"the results from DB query &quot;DBQuery_RDTermsSortOrder&quot; and response should match for field in json &quot;@name&quot;","status":"passed"}],"status":"passed"}}],"os":"Windows Server 2008 R2 6.1 x86","ip":"10.152.84.170","name":"Feature_LS-26075","time":"2019-06-18 09:53:51","url":"http://mwa.us-west-2.stable.dev.cortellis.int.clarivate.com","targettestcycle":"Smokes_Services_Stable_May24"}}]